Pooja A Lagisetty
Datos Biográficos
| ID | 5544073 |
|---|---|
| NOMBRE | Pooja A Lagisetty |
| NOMBRES | Pooja A |
| APELLIDO | Lagisetty |
| FIRMA | LAGISETTY P A |
| AFILIACIONES | VA Ann Arbor Healthcare System |
| VERIFICADO | No |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2019 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2019 |
| ÍNDICE H | 0 |
Buprenorphine Treatment Divide by Race/Ethnicity and Payment
Opioid mortality rates continue to increase throughout the United States 1 ; however, growth in buprenorphine hydrochloride treatment for opioid use disorder (OUD) might be limited to communities with higher income and low percentages of racial/ethnic minorities. 2 Buprenorphine, a partial opioid agonist, is 1 of 3 evidence-based medications for treating OUD and can legally be prescribed in office-based settings.
Opioid Prescribing After Opioid-related Inpatient Hospitalizations by Diagnosis
BACKGROUND: Any opioid-related hospitalization is an indicator of opioid-related harm and should ideally trigger carefully monitored decreases in opioid prescribing after inpatient stays in many, if not most, cases. However, past studies on opioid prescribing after hospitalizations have largely been limited to overdose related visits. It is unclear whether prescribing is different for other opioid-related indications such as opioid dependence and…
Sin obras prominentes en esta página.
Buprenorphine Treatment Divide by Race/Ethnicity and Payment
Opioid mortality rates continue to increase throughout the United States 1 ; however, growth in buprenorphine hydrochloride treatment for opioid use disorder (OUD) might be limited to communities with higher income and low percentages of racial/ethnic minorities. 2 Buprenorphine, a partial opioid agonist, is 1 of 3 evidence-based medications for treating OUD and can legally be prescribed in office-based settings.
Opioid Prescribing After Opioid-related Inpatient Hospitalizations by Diagnosis
BACKGROUND: Any opioid-related hospitalization is an indicator of opioid-related harm and should ideally trigger carefully monitored decreases in opioid prescribing after inpatient stays in many, if not most, cases. However, past studies on opioid prescribing after hospitalizations have largely been limited to overdose related visits. It is unclear whether prescribing is different for other opioid-related indications such as opioid dependence and…
Internal Medicine (2 obras) · Medicine (2 obras) · Opioid (2 obras) · Opioid Use Disorder Treatment (2 obras) · Substance Abuse Treatment and Outcomes (2 obras) · (+)-Naloxone (1 obras) · Anesthesia (1 obras) · Buprenorphine (1 obras) · Emergency Medicine (1 obras) · Emergency Medicine (1 obras)